Blue Earth Diagnostics Receives Positive Opinion For Axumin (Fluciclovine (18F)) For PET Imaging Of Recurrent Prostate Cancer Post author:Sam Post published:March 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like UK Charity to Use $638 Million Cash From Merck & Co.'s Blockbuster Keytruda to Back R&D June 14, 2017 SAGE Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update February 22, 2017 Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test October 9, 2017
UK Charity to Use $638 Million Cash From Merck & Co.'s Blockbuster Keytruda to Back R&D June 14, 2017
SAGE Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update February 22, 2017